Surface Expression of CD28 Single Chain Fv for Costimulation by Tumor Cells

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Immunological Reviews

• Publication date

  1996-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1600-065X.1996.tb00926.xPMID 9010725
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody.

  1998cited by this paper
• Regulation of T Cell Receptor Signaling by Tyrosine Phosphatase SYP Association with CTLA-4

  1996cited by this paper
• Enhancement of Antitumor Immunity by CTLA-4 Blockade

  1996cited by this paper
• Rapid and reliable cloning of antibody variable regions and generation of recombinant single chain antibody fragments.

  1996cited by this paper
• Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4

  1995cited by this paper
• A reassessment of the role of B7-1 expression in tumor rejection

  1995cited by this paper
• Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

  1994cited by this paper
• Binding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signalling

  1994cited by this paper
• The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3'-kinase

  1994cited by this paper
• Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol 3-kinase in Jurkat T cells

  1994cited by this paper
• Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody.

  1994cited by this paper
• CTLA-4 can function as a negative regulator of T cell activation.

  1994cited by this paper
• T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif.

  1994cited by this paper
• Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling

  1994cited by this paper
• Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody.

  1993cited by this paper
• Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack

  1993cited by this paper
• Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules.

  1993cited by this paper
• Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells.

  1993cited by this paper
• Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4.

  1992cited by this paper
• CTLA-4 is a second receptor for the B cell activation antigen B7

  1991cited by this paper
• Single-chain antigen-binding proteins.

  1988cited by this paper

• Agonists of Co-stimulation in Cancer Immunotherapy Directed Against CD137, OX40, GITR, CD27, CD28, and ICOS.

  2015cites this paper
• Membrane‐tethered proteins for basic research, imaging, and therapy

  2008cites this paper
• Tumor cells expressing anti-CD137 scFv induce a tumor-destructive environment.

  2007cites this paper
• Antitumor efficacy of CD137 ligation is maximized by the use of a CD137 single-chain Fv–expressing whole-cell tumor vaccine compared with CD137-specific monoclonal antibody infusion

  2006cites this paper
• Antibodies and gene therapy: teaching old 'magic bullets' new tricks.

  2004cites this paper
• Anti-4-1BB-based immunotherapy for autoimmune diabetes: lessons from a transgenic non-obese diabetic (NOD) model.

  2003cites this paper
• Therapeutic vaccination with tumor cells that engage CD137

  2003cites this paper
• Novel approaches to therapeutic cancer vaccines

  2003cites this paper
• Stable expression of chimeric anti-CD3 receptors on mammalian cells for stimulation of antitumor immunity

  2003cites this paper
• Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB

  2002cites this paper
• Development and applications of surface-linked single chain antibodies against T-cell antigens.

  2001cites this paper
• Design of transgenes for efficient expression of active chimeric proteins on mammalian cells.

  2001cites this paper
• Protein engineering by cell-surface display.

  2001cites this paper
• Activation of lymphocytes by anti-CD3 single-chain antibody dimers expressed on the plasma membrane of tumor cells

  2000cites this paper
• CTLA-4 (CD152) Surface-Linked Single-Chain Antibody to Blockade of T Cell Activation Using a

  2000cites this paper
• Blockade of T Cell Activation Using a Surface-Linked Single-Chain Antibody to CTLA-4 (CD152)1

  2000cites this paper
• Programmed cell death signaling via cell-surface expression of a single-chain antibody transgene.

  2000cites this paper
• PROGRAMMED CELL DEATH SIGNALING VIA CELL-SURFACE EXPRESSION OF A SINGLE-CHAIN ANTIBODY TRANSGENE

  2000cites this paper
• Expression of chimeric monomer and dimer proteins on the plasma membrane of mammalian cells.

  1999cites this paper
• [Molecular biology of antibodies].

  1998cites this paper
• Antibody engineering.

  1997cites this paper